Matches in SemOpenAlex for { <https://semopenalex.org/work/W1545734177> ?p ?o ?g. }
- W1545734177 endingPage "3680" @default.
- W1545734177 startingPage "3670" @default.
- W1545734177 abstract "BACKGROUND: Although lymphovascular invasion (LVI) has been associated with a poor outcome in patients with breast cancer, it is not included in most internationally recognized staging systems, including the American Joint Committee on Cancer tumor, lymph node, metastasis (TNM) classification. This is mainly because it remains unclear whether the presence of LVI is an independent, high-risk criterion in clinically relevant staging subgroups. METHODS: The current study was based on a large and well characterized consecutive series of patients who had operable (pathologic T1 [pT1]-pT2, pathologic N0 [pN0]-pN3, M0) breast cancer (3812 informative cases) who were treated according to standard protocols at a single institution and who had long-term follow-up to assess the prognostic value of definite LVI in clinically and molecularly relevant staging subgroups. RESULTS: LVI was strongly associated with both breast cancer-specific survival (BCSS) and distant metastasis-free survival (DMFS) in the entire series and in different subgroups. Multivariate analyses identified LVI as an independent predictor of both BCSS and DMFS in patients with operable breast cancer overall; in the TNM clinical subgroups pT1a-pT1c/pN0 and pT2/pN0; and in the molecular classes estrogen receptor (ER)-positive, ER-negative, human epidermal growth factor 2 [HER2]-negative, and triple-negative. In patients who had lymph node-negative tumors, LVI could be used as a high-risk criterion providing survival disadvantage equivalent to that provided by 1 or 2 involved lymph nodes (pN0 to pN1) and to that provided by 1 size category (pT1 to pT2). The use of immunohistochemistry for detecting an endothelial-specific marker contributed to the prognostic significance of LVI when applied to routine LVI negative/possible cases. CONCLUSIONS: LVI provided a strong predictor of outcome in patients with invasive breast cancer and should be incorporated into breast cancer staging systems. Cancer 2012. © 2011 American Cancer Society." @default.
- W1545734177 created "2016-06-24" @default.
- W1545734177 creator A5020838260 @default.
- W1545734177 creator A5039755304 @default.
- W1545734177 creator A5047699437 @default.
- W1545734177 creator A5052662513 @default.
- W1545734177 creator A5058755793 @default.
- W1545734177 creator A5075105813 @default.
- W1545734177 creator A5088178921 @default.
- W1545734177 creator A5090903889 @default.
- W1545734177 date "2011-12-16" @default.
- W1545734177 modified "2023-10-12" @default.
- W1545734177 title "The prognostic significance of lymphovascular invasion in invasive breast carcinoma" @default.
- W1545734177 cites W1748731440 @default.
- W1545734177 cites W1853173850 @default.
- W1545734177 cites W1872242587 @default.
- W1545734177 cites W1902814444 @default.
- W1545734177 cites W1968767144 @default.
- W1545734177 cites W1969684059 @default.
- W1545734177 cites W1976279830 @default.
- W1545734177 cites W1980046023 @default.
- W1545734177 cites W1983182396 @default.
- W1545734177 cites W1986657548 @default.
- W1545734177 cites W1999742177 @default.
- W1545734177 cites W1999931009 @default.
- W1545734177 cites W2001575298 @default.
- W1545734177 cites W2010355764 @default.
- W1545734177 cites W2010871781 @default.
- W1545734177 cites W2036251140 @default.
- W1545734177 cites W2040630328 @default.
- W1545734177 cites W2054270840 @default.
- W1545734177 cites W2056252863 @default.
- W1545734177 cites W2058502124 @default.
- W1545734177 cites W2066940652 @default.
- W1545734177 cites W2069742036 @default.
- W1545734177 cites W2074465378 @default.
- W1545734177 cites W2087481757 @default.
- W1545734177 cites W2103115336 @default.
- W1545734177 cites W2115867454 @default.
- W1545734177 cites W2124640147 @default.
- W1545734177 cites W2126730454 @default.
- W1545734177 cites W2128920415 @default.
- W1545734177 cites W2129120785 @default.
- W1545734177 cites W2137028370 @default.
- W1545734177 cites W2137570502 @default.
- W1545734177 cites W2143391647 @default.
- W1545734177 cites W2144183889 @default.
- W1545734177 cites W2151283634 @default.
- W1545734177 cites W2155802351 @default.
- W1545734177 cites W2155803397 @default.
- W1545734177 cites W2614539050 @default.
- W1545734177 doi "https://doi.org/10.1002/cncr.26711" @default.
- W1545734177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22180017" @default.
- W1545734177 hasPublicationYear "2011" @default.
- W1545734177 type Work @default.
- W1545734177 sameAs 1545734177 @default.
- W1545734177 citedByCount "188" @default.
- W1545734177 countsByYear W15457341772012 @default.
- W1545734177 countsByYear W15457341772013 @default.
- W1545734177 countsByYear W15457341772014 @default.
- W1545734177 countsByYear W15457341772015 @default.
- W1545734177 countsByYear W15457341772016 @default.
- W1545734177 countsByYear W15457341772017 @default.
- W1545734177 countsByYear W15457341772018 @default.
- W1545734177 countsByYear W15457341772019 @default.
- W1545734177 countsByYear W15457341772020 @default.
- W1545734177 countsByYear W15457341772021 @default.
- W1545734177 countsByYear W15457341772022 @default.
- W1545734177 countsByYear W15457341772023 @default.
- W1545734177 crossrefType "journal-article" @default.
- W1545734177 hasAuthorship W1545734177A5020838260 @default.
- W1545734177 hasAuthorship W1545734177A5039755304 @default.
- W1545734177 hasAuthorship W1545734177A5047699437 @default.
- W1545734177 hasAuthorship W1545734177A5052662513 @default.
- W1545734177 hasAuthorship W1545734177A5058755793 @default.
- W1545734177 hasAuthorship W1545734177A5075105813 @default.
- W1545734177 hasAuthorship W1545734177A5088178921 @default.
- W1545734177 hasAuthorship W1545734177A5090903889 @default.
- W1545734177 hasBestOaLocation W15457341771 @default.
- W1545734177 hasConcept C121608353 @default.
- W1545734177 hasConcept C126322002 @default.
- W1545734177 hasConcept C143998085 @default.
- W1545734177 hasConcept C146357865 @default.
- W1545734177 hasConcept C151730666 @default.
- W1545734177 hasConcept C2778740770 @default.
- W1545734177 hasConcept C2779013556 @default.
- W1545734177 hasConcept C2780849966 @default.
- W1545734177 hasConcept C29456083 @default.
- W1545734177 hasConcept C530470458 @default.
- W1545734177 hasConcept C71924100 @default.
- W1545734177 hasConcept C84606932 @default.
- W1545734177 hasConcept C86803240 @default.
- W1545734177 hasConceptScore W1545734177C121608353 @default.
- W1545734177 hasConceptScore W1545734177C126322002 @default.
- W1545734177 hasConceptScore W1545734177C143998085 @default.
- W1545734177 hasConceptScore W1545734177C146357865 @default.
- W1545734177 hasConceptScore W1545734177C151730666 @default.
- W1545734177 hasConceptScore W1545734177C2778740770 @default.